Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate Cancer
NCT04914195
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
155
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Prostate Adenocarcinoma
Interventions
DRUG:
Leuprolide Acetate 3.75 MG/ML
Sponsor
Bharat Serums and Vaccines Limited